Clinical Trials Browser

Phase NA × Esophageal Neoplasms × Risk Assessment × Clear all

NCT06306755 2025-01-24

ERSS-EGC

Phase NA Recruiting

21,000 enrolled

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms